Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Schenone

Showing results (131-140 of 199) with videos related to

Pageof 20
Sort By:
Journal of the Peripheral Nervous System : JPNS|October 13, 2015
Innovative quantitative testing of hand function in Charcot-Marie-Tooth neuropathyMaria A Alberti, Laura Mori, Luca Francini, et al.
Journal of the Peripheral Nervous System : JPNS|June 14, 2024
The neurological core features of the infantile-onset multisystem neurologic, endocrine, and pancreatic disease: A novel nonsense mutation in an Italian familyAlessia Mammi, Alessandro Geroldi, Serena Patrone, et al.
Frontiers in Neurology|September 28, 2020
Exploiting Sphingo- and Glycerophospholipid Impairment to Select Effective Drugs and Biomarkers for CMT1ADavide Visigalli, Giovanna Capodivento, Abdul Basit, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 24, 2014
Frequency and time to relapse after discontinuing 6-month therapy with IVIg or pulsed methylprednisolone in CIDPEduardo Nobile-Orazio, Dario Cocito, Stefano Jann, et al.
European Journal of Physical and Rehabilitation Medicine|November 12, 2016
Diagnosis and treatment of pain in plexopathy, radiculopathy, peripheral neuropathy and phantom limb pain. Evidence and recommendations from the Italian Consensus Conference on Pain on NeurorehabilitationFrancesco Ferraro, Marco Jacopetti, Vincenza Spallone, et al.
The Lancet. Neurology|March 12, 2011
Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trialDavide Pareyson, Mary M Reilly, Angelo Schenone, et al.
Life (Basel, Switzerland)|April 28, 2023
Comparing the Impact of COVID-19 on Vaccinated and Unvaccinated Patients Affected by Myasthenia GravisElena Scarsi, Sara Massucco, Pilar M Ferraro, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 23, 2020
CSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP and GBSGiovanna Capodivento, Chiara De Michelis, Marinella Carpo, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2021
Dysregulation of myelin synthesis and actomyosin function underlies aberrant myelin in CMT4B1 neuropathyMarta Guerrero-Valero, Federica Grandi, Silvia Cipriani, et al.
The Lancet. Neurology|May 15, 2012
Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trialEduardo Nobile-Orazio, Dario Cocito, Stefano Jann, et al.
Pageof 20

Showing results (131-140 of 199) with videos related to

Sort By:
Pageof 20
Journal of the Peripheral Nervous System : JPNS|October 13, 2015
Innovative quantitative testing of hand function in Charcot-Marie-Tooth neuropathyMaria A Alberti, Laura Mori, Luca Francini, et al.
Journal of the Peripheral Nervous System : JPNS|June 14, 2024
The neurological core features of the infantile-onset multisystem neurologic, endocrine, and pancreatic disease: A novel nonsense mutation in an Italian familyAlessia Mammi, Alessandro Geroldi, Serena Patrone, et al.
Frontiers in Neurology|September 28, 2020
Exploiting Sphingo- and Glycerophospholipid Impairment to Select Effective Drugs and Biomarkers for CMT1ADavide Visigalli, Giovanna Capodivento, Abdul Basit, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 24, 2014
Frequency and time to relapse after discontinuing 6-month therapy with IVIg or pulsed methylprednisolone in CIDPEduardo Nobile-Orazio, Dario Cocito, Stefano Jann, et al.
European Journal of Physical and Rehabilitation Medicine|November 12, 2016
Diagnosis and treatment of pain in plexopathy, radiculopathy, peripheral neuropathy and phantom limb pain. Evidence and recommendations from the Italian Consensus Conference on Pain on NeurorehabilitationFrancesco Ferraro, Marco Jacopetti, Vincenza Spallone, et al.
The Lancet. Neurology|March 12, 2011
Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trialDavide Pareyson, Mary M Reilly, Angelo Schenone, et al.
Life (Basel, Switzerland)|April 28, 2023
Comparing the Impact of COVID-19 on Vaccinated and Unvaccinated Patients Affected by Myasthenia GravisElena Scarsi, Sara Massucco, Pilar M Ferraro, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 23, 2020
CSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP and GBSGiovanna Capodivento, Chiara De Michelis, Marinella Carpo, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2021
Dysregulation of myelin synthesis and actomyosin function underlies aberrant myelin in CMT4B1 neuropathyMarta Guerrero-Valero, Federica Grandi, Silvia Cipriani, et al.
The Lancet. Neurology|May 15, 2012
Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trialEduardo Nobile-Orazio, Dario Cocito, Stefano Jann, et al.
Pageof 20